John Davis - CryoLife Senior Vice President - Global Sales and Marketing
President
Mr. John Davis is Senior Vice President Global Sales and Marketing of the Company . He has over 20 years of experience in Sales and Marketing and Executive Leadership. Prior to joining CryoLife, he served as Executive Vice President of Sales and Marketing at CorMatrix, a privately held medical device company creating innovative biomaterial devices to repair damaged heart tissue from March 2012 to September 2015. Prior to CorMatrix, he served for four years as a Vice President of Sales in the Cardiac Rhythm Management Devices business at St. Jude Medical, now part of Abbott Laboratories. Before St. Jude Medical, he served for 14 years with Medtronic in the Cardiac Rhythm Disease Management division in senior sales leadership roles. In his early career he served with Roche Diagnostics and CibaGeigy Corporation since 2015.
| Age | 55 |
| Tenure | 9 years |
| Phone | 770 426-0031 |
| Web | www.Artivion.com |
CryoLife Management Efficiency
The company has Return on Asset of 1.01 % which means that on every $100 spent on assets, it made $1.01 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.57 %, implying that it generated $0.57 on every 100 dollars invested. CryoLife's management efficiency ratios could be used to measure how well CryoLife manages its routine affairs as well as how well it operates its assets and liabilities.CryoLife has 363.37 M in debt with debt to equity (D/E) ratio of 1.17, which is OK given its current industry classification. CryoLife has a current ratio of 4.13, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for CryoLife to invest in growth at high rates of return.
Similar Executives
| Found 14 records | PRESIDENT Age | ||
| Silviu Popovici | PepsiCo | 56 | |
| John Enwright | Vera Bradley | 51 | |
| Navroop Sandhawalia | SNDL Inc | ||
| Monique Matheson | Nike Inc | 57 | |
| Kirk Tanner | PepsiCo | 55 | |
| John Slusher | Nike Inc | 49 | |
| Taranvir Vander | SNDL Inc | 46 | |
| Tyler Robson | SNDL Inc | 35 | |
| Matthew Friend | Nike Inc | 46 | |
| Chris Abston | Nike Inc | 54 | |
| Andrew Campion | Nike Inc | 52 | |
| Craig Williams | Nike Inc | 54 | |
| Hilary Krane | Nike Inc | 56 | |
| Marcie Kiziak | SNDL Inc | 44 | |
Management Performance
| Return On Equity | 0.57 | |||
| Return On Asset | 1.01 |
CryoLife Leadership Team
Elected by the shareholders, the CryoLife's board of directors comprises two types of representatives: CryoLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CryoLife. The board's role is to monitor CryoLife's management team and ensure that shareholders' interests are well served. CryoLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CryoLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Mackin, Chairman of the Board, President, Chief Executive Officer, Director | ||
| Anthony Semedo, Independent Director | ||
| Daniel Bevevino, Independent Director | ||
| Dennis Maier, Vice President - Operations | ||
| Ronald McCall, Presiding Independent Director | ||
| Thomas Bogenschutz, Senior Vice President - EMEA, General Manager - Hechingen | ||
| Jeffrey Burbank, Independent Director | ||
| Jon Salveson, Independent Director | ||
| Jean Holloway, Senior Vice President, Chief Compliance Officer, General Counsel, Secretary | ||
| Thomas Ackerman, Independent Director | ||
| F Barthold, Vice President - Research and Development | ||
| Harvey Morgan, Independent Director | ||
| Amy Horton, Chief Accounting Officer, Vice President | ||
| Scott Capps, Vice President - Clinical Research | ||
| Marna Borgstrom, Independent Director | ||
| Michael Simpson, Senior Vice President - Regulatory Affairs and Quality Assurance | ||
| John Davis, Senior Vice President - Global Sales and Marketing | ||
| James Bullock, Independent Director | ||
| Matthew Getz, Vice President - Human Resources | ||
| D Lee, Chief Financial Officer, Chief Operating Officer, Executive Vice President |
CryoLife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CryoLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.57 | |||
| Return On Asset | 1.01 | |||
| Profit Margin | 0.63 % | |||
| Operating Margin | 12.82 % | |||
| Current Valuation | 1.07 B | |||
| Shares Outstanding | 39.33 M | |||
| Shares Owned By Insiders | 3.70 % | |||
| Shares Owned By Institutions | 83.78 % | |||
| Number Of Shares Shorted | 3.47 M | |||
| Price To Earning | 425.71 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in CryoLife Stock
If you are still planning to invest in CryoLife check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CryoLife's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |